SILVERBERG: As a board-certified dermatologist in an academic referral center, I encounter a substantial caseload of patients with atopic dermatitis and other chronic inflammatory skin conditions.
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Megan Rogge, MD, Associate Professor of Dermatology at McGovern Medical School, UTHealth Houston, details the varied conversations with patients that are often necessary before inititating treatment ...
There are some 40 interleukins that play a wide variety of roles in inflammation and the body’s immune response, some of them hitting the accelerator and others tapping the brakes. When it comes to ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.
Akeso, Inc. (($HK:9926)) announced an update on their ongoing clinical study. Akeso, Inc. is conducting a clinical study titled ‘A Multicenter, ...
Atopic dermatitis, the most common form of eczema, is a widespread skin condition known for causing dry, itchy and inflamed skin. It affects 15% to 20% of children and 8% to 10% of adults. The ...
The itch won’t quit. So you scratch. Then your skin burns, cracks, and flares. If you have atopic dermatitis (AD), you know the cycle all too well. Maybe you’ve tried steroid creams or other ointments ...
Please provide your email address to receive an email when new articles are posted on . Attending conferences, reading journals and browsing informative websites are the best ways to stay up to date ...
INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...
AJMC®: What is your experience with determining coverage criteria for patients with atopic dermatitis? LOPES: As a physician with extensive experience in managed care, I’ve been deeply involved in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results